Infection Control Market Analysis and Forecast to 2031: By Product & Services (Sterilization Products & Services, Cleaning & Disinfection Products, Protective Barriers, Endoscope Reprocessing Products, Other), End User (Hospitals & Clinics, Medical Device

Infection Control Market Analysis and Forecast to 2031: By Product & Services (Sterilization Products & Services, Cleaning & Disinfection Products, Protective Barriers, Endoscope Reprocessing Products, Other), End User (Hospitals & Clinics, Medical Device Companies, Pharmaceutical Companies, Life Science Industry, Food Industry, Other), and Region

The infection control market was valued at USD 32.0 billion in 2021 and it is anticipated to grow further up to USD 42.6 billion by 2031, at a CAGR of 2.9% during the forecast period.


Most infections are brought on by microorganisms like bacteria, fungus, viruses, or parasites. There are many various sorts of infections, including those that affect the stomach and intestines, the lungs and respiratory system, the eyes, ears, and skin, as well as those that are spread through sexual activity. Cross-contamination from the patient's skin, medical equipment, and staff can result in these illnesses. Sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing items are some of the various kinds of goods and services available to control infections.

Market Trends and Drivers

The number of surgical operations carried out globally has significantly increased over time. Around 235 million major surgical procedures are carried out annually worldwide, according to the WHO (2019). This is ascribed to the rising senior population, the prevalence of obesity and other lifestyle disorders, the rise in spinal injuries, and the rise in sports-related injuries. The demand for various surgical equipment and medical devices used during these procedures has increased as more surgical procedures are being conducted. Due to the established advantages of sterilized items and increased awareness of their efficiency in infection control health settings, this is projected to fuel the need for infection control products and services. The number of surgical procedures performed in the US has significantly increased over the past ten years, according to the National Center for Biotechnology Information (NCBI, US), and this trend is anticipated to continue in the years to come. According to the American Society of Plastic Surgeons (ASPS), 1.8 million surgical cosmetic treatments and 15.9 million minimally invasive cosmetic procedures were carried out in the US in 2019. These figures indicated increases of 2% and 1% above the procedures carried out in 2017. Additionally, during that time 5.8 million reconstructive surgeries were carried out in the US.

Market Restraints and Challenges

The majority of chemical disinfectants that are currently on the market have hazardous qualities. For instance, sodium hypochlorite, a substance used to treat blood-borne diseases, is effective but also highly corrosive and irritating to the respiratory system, making it poisonous when released into the environment and dangerous to cleaning staff and building occupants. When these disinfectants are used incorrectly, they can affect patients who are exposed to them as well as the environment. The Federal Insecticide, Fungicide, and Rodenticide Act regulates the sale of disinfectants in the US, and the Environmental Protection Agency (EPA) defines these products as pesticides (FIFRA). At this time, there isn't a green certificate for disinfectants on the market. Disinfectants are now only used on a small number of non-critical products and in reduced amounts as a result of the expanding end-user population's demand for a greener alternative. The development of newer, more environmentally friendly disinfectants that are less harmful to human eyes, like butyl-free, pH-neutral quaternary, and hydrogen peroxide-based disinfectants, is now required of manufacturers. In keeping with this, Clorox Healthcare introduced its new alcohol-free Clorox Healthcare Versa-Sure Cleaner Disinfectant Wipes in 2018.

Global Infection Control Market Segmental Overview

The report analyses the global infection control market based on the products & services, end user, and region.

Global Infection Control Market by Product & Services

Based on the products & services, it is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and others. The protective barriers segment is anticipated to dominate the market during the forecast period. The large share of the protective barrier market can be attributed to the increasing adoption of medical nonwovens, such as face masks and surgical drapes & gown, owing to the current rise in the COVID-19 cases.

Global Infection Control Market by End User

Based on the end user, it is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, life science industry, food industry, and others. The hospitals & clinics end-user segment is anticipated to dominate the market during the forecast period. The increased incidence of HAIs, the rising number of hospitals and clinics around the world, and the growing elderly population are the main factors driving the total demand for infection control in hospitals (as this population segment is more susceptible to various chronic diseases). The expanding number of surgical procedures performed is another important factor in the expansion of the hospital market. A prominent driver of the market sector is the increase in government activities to guarantee a high degree of infection prevention.

Geographical Analysis of Infection Control Market

Region-wise, it is segmented into studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America region is accounted for the majority of market share during the forecast period. The significant share of the area may be ascribed to the rising focus on healthy lifestyles and disease prevention among consumers, which has led to an increase in the demand for and adoption of sterilization and disinfection products as well as services. The rise in the number of elderly people in the coming years will lead to an increase in the prevalence of chronic diseases, the need for infection control to reduce the prevalence of HAIs, the adoption of positive government initiatives, and strict sterilization and disinfection regulations, and other factors are all driving the infection control market in the region.

Major Players in the Global Infection Control Market COVID-19 Impact

Healthcare systems around the world have been affected by the pandemic, with hospitals being overrun by the growing number of patients. In order to handle the increasing number of victims, temporary hospitals are also being established. Due to the increased awareness of cleanliness, health, and safety, the proliferation of COVID-19 has consequently sparked a boom in demand for cleaning and disinfection goods. A few of the key factors influencing the demand and uptake of antiseptics and disinfectants in the region are the rising healthcare costs in North America and the rise of temporary hospitals. Furthermore, numerous steps are being done by businesses and governmental organizations to spur market growth as a result of the present COVID-19 pandemic that is spreading devastation around the world. For instance, the FDA has advocated that Sterigenics reopen its US facility for ethylene oxide-based sterilization. Due to dangerous fumes that were thought to be carcinogenic, the factory had been shut down. The facility was authorized to reopen in March 2020 for a 21-day period in order to sanitize personal protective equipment (PPE) for use by healthcare workers during the COVID-19 pandemic. It is anticipated that these advances will fuel the market for infection control.

Recent Developments

• January 2021, STERIS signed a definitive agreement to acquire Cantel, a global provider of infection prevention products and services, through a US subsidiary, to diversify its vast portfolio of infection control products & services.
• May 2020, Getinge launched its new Getinge Assured Superfast 20 Biological Indicators that allows CSSD staff to obtain results in 20 minutes.
• December 2020, Cantel partnered with Censis to combine Cantel’s leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis under one brand-CANEXIS Integrated Workflow Solution – to offer and instrument reprocessing and scope tracking software.
• December 2020, Ecolab acquired Holchem Group to strengthen its hygiene and cleaning products and services portfolio for the food & beverages, food service, and hospitality industries.

Frequently Asked Questions

Q1. How big is the Infection Control market?Ans. The global Infection Control market size was USD 32.0 Billion in 2021 and is anticipated to reach USD 42.6 Billion in 2031, growing at a rate of 2.9% from 2022 to 2031.
Q2. What is the Infection Control market growth rate?Ans. The growth rate of the Infection Control market is 2.9%.
Q3. Which region holds a major market share for the Infection Control market?Ans. North America holds a major market share of the Infection Control market in 2021.
Q4. Which segment accounted for the largest Infection Control market share?Ans. By end user, hospitals & clinics segment accounted for the largest Infection Control market share.
Q5. Who are the key players in the Infection Control market?
Q6. What are the factors driving the Infection Control market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.
Q7. What are the key growth strategies of Infection Control market players?Ans. The key growth strategies of Infection Control market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Infection Control market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Infection Control market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.